Zacks: Brokerages Expect CME Group Inc. (CME) Will Announce Earnings of $1.17 Per Share
Equities research analysts expect CME Group Inc. (NASDAQ:CME) to announce earnings per share of $1.17 for the current fiscal quarter, Zacks reports. Four analysts have made estimates for CME Group’s earnings. The highest EPS estimate is $1.25 and the lowest is $1.09. CME Group posted earnings of $1.05 per share in the same quarter last year, which indicates a positive year over year growth rate of 11.4%. The firm is scheduled to report its next earnings results on Thursday, October 26th.
On average, analysts expect that CME Group will report full year earnings of $4.81 per share for the current year, with EPS estimates ranging from $4.59 to $4.98. For the next year, analysts anticipate that the business will report earnings of $5.27 per share, with EPS estimates ranging from $5.04 to $5.49. Zacks Investment Research’s earnings per share averages are a mean average based on a survey of research analysts that that provide coverage for CME Group.
CME Group (NASDAQ:CME) last released its quarterly earnings data on Tuesday, August 1st. The financial services provider reported $1.23 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $1.20 by $0.03. The firm had revenue of $925 million during the quarter, compared to analysts’ expectations of $931.05 million. CME Group had a return on equity of 7.61% and a net margin of 46.05%. CME Group’s revenue was up 2.1% compared to the same quarter last year. During the same quarter in the prior year, the business posted $1.14 earnings per share.
A number of brokerages have issued reports on CME. UBS AG reiterated a “buy” rating and set a $134.00 price target (down previously from $136.00) on shares of CME Group in a research report on Monday, June 5th. Zacks Investment Research lowered CME Group from a “hold” rating to a “sell” rating in a report on Tuesday, July 11th. Keefe, Bruyette & Woods restated a “hold” rating and issued a $127.00 price objective on shares of CME Group in a report on Friday, July 14th. BidaskClub lowered CME Group from a “hold” rating to a “sell” rating in a report on Friday, July 28th. Finally, Deutsche Bank AG cut their price objective on CME Group from $139.00 to $136.00 and set a “buy” rating for the company in a report on Tuesday, July 4th. One research analyst has rated the stock with a sell rating, three have assigned a hold rating and five have assigned a buy rating to the company’s stock. The stock has an average rating of “Hold” and an average target price of $131.63.
In other news, Director Ronald A. Pankau sold 300 shares of the company’s stock in a transaction on Thursday, August 3rd. The stock was sold at an average price of $124.78, for a total value of $37,434.00. Following the completion of the sale, the director now owns 4,009 shares in the company, valued at $500,243.02. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, Director Timothy S. Bitsberger sold 800 shares of the company’s stock in a transaction on Tuesday, June 13th. The shares were sold at an average price of $125.93, for a total value of $100,744.00. Following the completion of the sale, the director now owns 9,024 shares of the company’s stock, valued at approximately $1,136,392.32. The disclosure for this sale can be found here. In the last 90 days, insiders sold 69,770 shares of company stock valued at $8,569,114. Insiders own 0.61% of the company’s stock.
Several large investors have recently made changes to their positions in the company. Huntington National Bank raised its stake in shares of CME Group by 4.7% in the first quarter. Huntington National Bank now owns 851 shares of the financial services provider’s stock worth $100,000 after buying an additional 38 shares during the period. Coconut Grove Bank raised its stake in shares of CME Group by 95.7% in the first quarter. Coconut Grove Bank now owns 900 shares of the financial services provider’s stock worth $107,000 after buying an additional 440 shares during the period. Whittier Trust Co. raised its stake in shares of CME Group by 12.6% in the first quarter. Whittier Trust Co. now owns 1,030 shares of the financial services provider’s stock worth $122,000 after buying an additional 115 shares during the period. Parallel Advisors LLC raised its stake in shares of CME Group by 4.1% in the first quarter. Parallel Advisors LLC now owns 1,084 shares of the financial services provider’s stock worth $128,000 after buying an additional 43 shares during the period. Finally, RidgeWorth Capital Management LLC raised its stake in shares of CME Group by 55.5% in the first quarter. RidgeWorth Capital Management LLC now owns 1,138 shares of the financial services provider’s stock worth $135,000 after buying an additional 406 shares during the period. 83.17% of the stock is currently owned by institutional investors.
CME Group (NASDAQ:CME) traded up 0.67% on Friday, reaching $125.83. The company’s stock had a trading volume of 1,222,844 shares. CME Group has a 52-week low of $98.95 and a 52-week high of $127.96. The firm has a market capitalization of $42.60 billion, a P/E ratio of 25.68 and a beta of 0.73. The firm has a 50-day moving average price of $123.71 and a 200 day moving average price of $120.57.
The company also recently disclosed a quarterly dividend, which will be paid on Monday, September 25th. Stockholders of record on Friday, September 8th will be issued a $0.66 dividend. The ex-dividend date is Thursday, September 7th. This represents a $2.64 annualized dividend and a dividend yield of 2.10%. CME Group’s dividend payout ratio (DPR) is 53.99%.
CME Group Company Profile
CME Group Inc, through its exchanges, provides products across all asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products and metals. The Company’s segment primarily consists of the Chicago Mercantile Exchange Inc (CME), Board of Trade of the City of Chicago, Inc (CBOT), New York Mercantile Exchange, Inc (NYMEX) and Commodity Exchange, Inc (COMEX) exchanges.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for CME Group Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group Inc. and related companies with MarketBeat.com's FREE daily email newsletter.